Richard Ramko is a partner in Ernst & Young's South Florida practice, primarily serving publicly-held and emerging growth companies in the Health Sciences, Biotech and Technology industries.
Ramko has extensive experience serving large, publicly-held companies as well as newly formed start-ups and venture-backed enterprises. Richard has 15 years of experience, including 13 years in public accounting and 2 years in executive level financial positions in private industry and is a certified public accountant in Florida and Tennessee. Some of his current clients include Andrx Corporation, Nabi Biopharmaceuticals, Stiefel Laboratories and SFBC International.
One strong indicator of the biotech industry is the financing that have occurred in the past year. 2005 marks the third year in a row that the US biotech industry has raised very robust amounts of capital. The sector raised $14.6 billion in 2005 compared with $16.9 billion in 2004, and $14.3 billi...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
